Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-032279
Filing Date
2023-05-25
Accepted
2023-05-25 18:38:21
Documents
1
Period of Report
2023-05-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4548
  Complete submission text file 0001209191-23-032279.txt   5888
Mailing Address C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE, 4TH FLOOR CAMBRIDGE MA 02139
Business Address
Rhodes Jason P (Reporting) CIK: 0001577014 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39509 | Film No.: 23962469

Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Issuer) CIK: 0001818794 (see all company filings)

EIN.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations